Integrated Safeguards Data Sheet

advertisement
INTEGRATED SAFEGUARDS DATA SHEET
CONCEPT STAGE
Report No.: AC3094
Date ISDS Prepared/Updated: 07/24/2007
I. BASIC INFORMATION
A. Basic Project Data
Country: Djibouti
Project ID: P102842
Project Name: Avian Influenza and Human Pandemic Preparedness
Task Team Leader: Jean-Philippe Tre
Estimated Appraisal Date:
Estimated Board Date:
Managing Unit: MNSSD
Lending Instrument: Emergency Recovery
Loan
Sector: Health (50%);Animal production (25%);Agricultural extension and research
(25%)
Theme: Other communicable diseases (P);Other rural development (P)
SPF Amount (US$m.):
0.00
GEF Amount (US$m.):
0.00
PCF Amount (US$m.):
0.00
Other financing amounts by source:
Borrower
0.00
Avian and Human Influenza Facility
2.11
2.11
B. Project Objectives [from section 2 of PCN]
The overall objective of the Grant is to contain and prevent the emergence of Highly Pathogenic
Avian Influenza (HPAI) in domestic poultry, and to prepare for, control and respond to an
influenza pandemic and other infectious disease emergencies in humans.
C. Project Description [from section 3 of PCN]
Component 1: Animal Health and Veterinary Services
This component will provide support for the strengthening of veterinary services through
assistance for:
1.Disease control and management capacity: this sub-component will support the following
activities: (a) culling of infected and at-risk poultry; (b) compensation to farmers and producing
companies; (c) disposal of carcasses and potentially infective materials in a biosecure and
environmentally acceptable manner; (d) enhanced bio-security at poultry farms and associated
premises, through bio-containment and bio-exclusion training and community awareness
programs; (e) vaccination of poultry and use of good quality and non anti-viral HPAI vaccines
produced according to OIE standards and implemented according to FAO/OIE guidelines. The
sub-component would also provide basic bio-security equipment such as sprayers, protective
equipment.
2. Improved Laboratory services capacity: The diagnostic capacity of public veterinary services
will be improved through the upgrading of the existing veterinary laboratory in Djibouti city and
training for laboratory technicians. This subcomponent will provide support for rapid testing
capacity and acquisition of modern laboratory equipment.
3. Improved regulatory and legal framework of veterinary services: this sub-component will
support reviews of existing regulation and policies to address key policies issues to ensure that
the recommended disease control, prevention and eradication measures are implemented in a
uniform way and in accordance with OIE standards and guidelines. It will also provide support
for key diagnostic and assessment studies, including national poultry census and sector
restructuring options.
4. Strengthened animal disease surveillance and diagnostic capacity building through: (a)
provision of technical assistance, and training to field and quarantine staff; (b) improvement of
animal health information flow among relevant agencies; (c) rapid detection, reporting and
follow-up of reported cases; (d) routine serological surveys and epidemio-surveillance at
migratory birds habitats and backyard levels; (e) the establishment of public and communitybased animal disease surveillance and early warning networks to support a robust emergency
reporting and feedback system against notifiable diseases. The sub-component would also
support training for animal health workers, and treatment of infected animals and reporting
procedures.
5. Improved human resources through support for two-year curriculum training for new
veterinary technicians
Component 2: Public Health Services
This component seeks to prevent the emergence of a human pandemic through the rapid
identification and effective management of human cases. It will provide support for:
1. Improved diagnostic capacity and effective management of human cases: this sub-component
will finance the procurement and distribution of medicine, personal protective equipment for atrisk population and medical staff. Anti-viral drugs will not be eligible for support. The subcomponent will also provide support for the acquisition of modern equipment for laboratory
diagnostic as well as provision of laboratory consumables, specimen collection kits and
transports costs associated with sending the specimens to the WHO collaborating center.
2. Improved surveillance, investigation and response capacity: this sub-component will support
establishment and training of rapid response teams as well as operating costs associated with
surveillance, investigation, and response activities, including vehicle purchase and necessary
logistics
3. Technical training for health staff: this activity will support: (a) training for medical staff on
social distancing measures, treatment guidelines, protocols and procedures for managing medical
waste and hospital infection control guidelines, including strategies to increase hospital bed
availability; (b) training for health field workers on surveillance measures, case detection and
reporting, clinical and virological surveillance criteria and reporting protocols/systems for
influenza-like symptoms and fevers of unknown origin; (c) practical training of laboratory
technicians on the application of special quality control and bio-safety guidelines.
Component 3: Communication and public awareness
This component would provide support for information and communication activities to
increase the attention and commitment of government, private sector and civil society and to
raise awareness of the general population about the risk and potential impact of the pandemic.
Specific activities would include: (a) the development of a communications strategy to advocate,
inform and seek a rapid-reporting and rapid-response behavior from society; (b) information
sharing and training workshops for public sector advocacy, media and journalists, local NGOs,
civil society and technical staff in Ministries of Health and Agriculture; (c) broadcast media
production and dissemination; (d) establishment and operation of an avian influenza hotline; (e)
information baseline and research studies as well as media monitoring and evaluation activities;
(e) production of educational toolkits for community training, education and mobilization.
D. Project location (if known)
This project will be implemented nationwide in Djibouti.
For specific components, certain provinces are targeted where reference and regional
laboratories exist (for strengthening of animal disease surveillance capacity).
E. Borrower’s Institutional Capacity for Safeguard Policies [from PCN]
The counterpart will need capacity building regarding safeguards policies, and quality control
assistance.
F. Environmental and Social Safeguards Specialists
Ms Stefanie U.S. Brackmann (AFTEN)
II. SAFEGUARD POLICIES THAT MIGHT APPLY
Safeguard Policies Triggered
Yes
No
TBD
Environmental Assessment (OP/BP 4.01)
X
The safeguard issues which pertain to the Project are (i) selection and implementation of
culling methods; (ii) selection and implementation of disposal methods for culled poultry and
associated waste; (ii) safe disposal of medical waste; and (iv) mitigating the negative economic
impacts of disease-inducted death and/or mandated culling of poultry on small-scale and
backyard poultry producers.
Overall, the Project would assist the government entities to develop a strategy for managing
future emerging and re-emerging diseases outbreaks. As such the project will improve
environmental and social safeguards in following areas: (i) mainstreaming environmental
safeguards into protocols and procedures for the culling and disposal of animals during an
Safeguard Policies Triggered
Yes
No
TBD
outbreak, in particular by adopting OIE standards in these areas, and improving bio-medicalwaste management systems in health facilities and laboratories; (ii) financing safe culling and
disposal options; and (iii) development of policies on compensation for poultry farmers affected
by future outbreaks.
Natural Habitats (OP/BP 4.04)
X
Forests (OP/BP 4.36)
X
Pest Management (OP 4.09)
X
It is very likely that chemicals will be used for the culling of birds. The procurement of any
pesticide will be contingent on an assessment of the nature and degree of associated risks, taking
into account the proposed use and the intended users. The Project will require that any pesticides
it finances be manufactured, packaged, labeled, handled, stored, disposed of, and applied
according to standards acceptable to the Bank. The Bank does not finance formulated products
that fall in WHO classes IA and IB, or formulations of products in Class II, if (a) the country
lacks restrictions on their distribution and use; or (b) they are likely to be used by, or be
accessible to, lay personnel, farmers, or others without training, equipment, and facilities to
handle, store, and apply these products properly.
Whatever medical waste is generated in health care facilities and waste from the animal
health component will be managed using existing guidelines in the countries. The country project
will also support updating these guidelines, training of health care workers to manage medicinal
waste following these guidelines and the purchase of equipment for the proper handling and
disposal of medical waste in selected facilities. This provision would be included in the project
operational manual (or equivalent).
Physical Cultural Resources (OP/BP 4.11)
X
Indigenous Peoples (OP/BP 4.10)
X
Involuntary Resettlement (OP/BP 4.12)
X
Safety of Dams (OP/BP 4.37)
X
Projects on International Waterways (OP/BP 7.50)
X
Projects in Disputed Areas (OP/BP 7.60)
X
Environmental Category: B - Partial Assessment
III. SAFEGUARD PREPARATION PLAN
A. Target date for the Quality Enhancement Review (QER), at which time the PAD-stage ISDS
would be prepared: N/A
B. For simple projects that will not require a QER, the target date for preparing the PAD-stage
ISDS: 07/31/2007
C. Time frame for launching and completing the safeguard-related studies that may be needed.
The specific studies and their timing1 should be specified in the PAD-stage ISDS.
Since the project supports investments for the culling and disposal of carcasses and
laboratory wastes, a short Environmental Management Plan (EMP) will be prepared. The
EMP will cover the selection of appropriate culling methods, clean-up of animal wastes of
infected and culled poultry; selection and management of disposal facilities. The scope of
this EMP will be specified during the initial period of Project implementation.
IV. APPROVALS
Signed and submitted by:
Task Team Leader:
Mr Jean-Philippe Tre
Approved by:
Regional Safeguards Coordinator:
Mr Sherif Kamel F. Arif
Comments:
Sector Manager:
Mr Luis F. Constantino
Comments: Note: The SD team member was Tigaust Fisseha.
1
Reminder: The Bank's Disclosure Policy requires that safeguard-related documents be disclosed before appraisal (i) at the
InfoShop and (ii) in-country, at publicly accessible locations and in a form and language that are accessible to potentially affected
persons.
Download